Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Felcoon Mar 16, 2018 1:19pm
283 Views
Post# 27728831

RE:analyst credibility ???

RE:analyst credibility ???They have given their estimates as to the what they believe the inherent value of the company is and where they believe it will be.  At least they base the evaluations on methodology and not on their gut feelings at the beginning of each day. Interesting how they all have targets well above current trading levels and with the exception of a couple of outliers have similar numbers.  Delays have factored into the equation and they have adjusted accordingly.  

That said, they do not control the market and their influence is limited in so far as driving share value (obviously) when a company comes into the crosshairs of market manipulators and assorted scum bags with their dubious reports.

Good luck,
Felco
Bullboard Posts